US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Jan. 13 for "Use of FK506 for the treatment of pulmonary arterial hypertension" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,379, issued on Jan. 13, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Use of FK506 for the treatment of pulmonary arterial hypertension" was invented by Edda Spiekerkoetter (Redwood City, Calif.), Marlene Rabinovitch (Redwood City, Calif.), Philip A. Beachy (Redwood City, Calif.) and David Solow-Cordero (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for reducing pulmonary hypertension in a mammal that employs FK506 is provided. In certain embodiments, the method comprises administering FK506 to a mammal having pulmonary arterial hypertension associated with defectiv...